FDG PET/CT in a 168 kg Patient with Hyperglycemia
A 54-year-old man, 168 kg and 1.75 m (BMI 55), with diffuse large B-cell lymphoma is booked for staging FDG PET/CT at 13:00. Protocol: 5.2 MBq/kg (0.14 mCi/kg), departmental maximum 555 MBq (15 mCi), 60 minutes uptake, 2 min per bed position, 6 bed positions, TOF scanner (227-kg table limit, 70-cm aperture). Fasting glucose is 212 mg/dL (11.8 mmol/L); he last ate 9 hours ago and takes metformin only. The next open scanner slot is in 4 days, but chemotherapy is scheduled to start tomorrow morning and the oncologist needs nodal staging to choose between two regimens. His only IV access is a 22-gauge catheter in the left hand. The camera schedule is full until 17:00.
1. Weight-based dosing gives 23.5 mCi, which exceeds your 15 mCi departmental cap. How do you resolve that conflict?
Read the worked answer
The numbers: 5.2 MBq/kg × 168 kg ≈ 874 MBq (≈23.5 mCi); the cap truncates this to 555 MBq (15 mCi), a 36% reduction.
The physics: image noise scales as √counts, and in a patient of this size attenuation and scatter are both severe. Cutting activity by 36% costs roughly 20% of the signal-to-noise ratio at a fixed bed time - in exactly the patient population where lesion detectability is already marginal.
Two defensible solutions; pick one explicitly and document it:
- Weight-based activity with AU/RSO approval (≈23 mCi). Whole-body effective dose rises roughly proportionally (order of 7 → 10–11 mSv) - well within justified diagnostic range for staging that determines a treatment regimen.
- Keep 15 mCi and lengthen the emission acquisition, e.g., 4 min/bed instead of 2, doubling counts and improving SNR by ~40%. This is the more ALARA-friendly lever, but it adds ~12 min of scanner time.
Given the fully booked schedule until 17:00, option 1 plus longer bed times for the noisiest bed positions is realistic. Either way, use TOF/PSF reconstruction, CT-based attenuation correction with tube-current modulation, and arms-up positioning.
2. Glucose is 212 mg/dL. Do you proceed, reschedule, or treat - and how does the timing of insulin matter?
Read the worked answer
Do not cancel reflexively, and do not give insulin and scan immediately.
- Hyperglycemia competitively reduces FDG uptake through GLUT translocation and hexokinase activity. The effect is not uniform: tumor-to-background ratio falls, and low-avidity lesions can disappear. Liver (reference) uptake also shifts.
- Insulin given shortly before injection is worse than the hyperglycemia: it drives FDG into skeletal muscle and myocardium, degrading the tumor-to-background ratio, and risks hypoglycemia during the 60-minute uptake in a fasting patient.
- If you treat, use rapid-acting insulin and wait roughly 3–4 hours before injecting.
- Here, with chemotherapy starting tomorrow and a four-day wait for the scanner, the pragmatic answer is proceed and document: note the glucose value, the fasting interval, and the caveat that SUV-based thresholds are less reliable and false negatives are possible. Interpret with liver and mediastinal blood-pool references rather than absolute cutoffs.
- Metformin: causes intense bowel uptake. Holding it for 48 hours helps when bowel/abdominal nodal assessment matters, but that window has passed; do not stop it now and do not delay the study for it.
3. What technical and patient-care issues does the 22-gauge hand catheter raise, and what else do you check before scanning this patient?
Read the worked answer
IV access
- A 22-gauge hand vein is a high-risk site for extravasation, which at 15–23 mCi would produce a hot injection site plus lymphatic streaking and could render the study uninterpretable.
- Before injecting: flush with saline and confirm free flow with no resistance or swelling, warm the arm, and if a larger antecubital vein can be obtained, use it. Watch the site during the injection and ask the patient to report burning.
Scanner/patient factors
- 168 kg is under the 227-kg table limit and fits the 70-cm aperture, but the body habitus increases the CT scan radius and noise: check automatic exposure control and raise the tube current within the protocol if the attenuation-correction map is noisy.
- Arms up reduces attenuation but increases the CT field width - confirm the patient can hold the position for the full acquisition.
- Confirm fasting (9 h is adequate), no strenuous exercise in the last 24 h, no recent contrast that would confound, and that the diabetes history is documented.
- Report the limitation in the final interpretation so the oncologist knows the study is staging-grade but not quantitatively pristine.